Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 960
Filter
1.
BMC Oral Health ; 24(1): 527, 2024 May 03.
Article in English | MEDLINE | ID: mdl-38702671

ABSTRACT

BACKGROUND: This study aimed to assess and compare the concentrations of growth factors, white blood cells (WBCs), and platelets in injectable platelet-rich fibrin (i-PRF) derived from people with healthy periodontal conditions and those with chronic periodontitis. METHODS: Venous blood samples were obtained from 30 patients diagnosed with chronic periodontitis (test group) and 30 participants with healthy periodontal conditions (control group). The i-PRF was then acquired from centrifuged blood. The growth factors (VEGF, IGF-1, TGF-ß1, PDGF-BB and EGF) released from the i-PRF samples were compared between groups with ELISA testing. The amounts of WBCs and platelets were also compared. RESULTS: No significant differences in the concentrations of growth factors were found between the groups (the mean values for the control and test groups were, respectively: IGF: 38.82, 42.46; PDGF: 414.25, 466.28; VEGF: 375.69, 412.18; TGF-ß1: 21.50, 26.21; EGF: 138.62, 154.82). The test group exhibited a significantly higher WBC count than the control group (8.80 vs. 6.60, respectively). However, the platelet count did not show a statistically significant difference between the groups (control group 242.0 vs. test group 262.50). No significant correlation was observed between WBC count and growth factor level in either group. CONCLUSIONS: The growth factor levels in i-PRFs did not exhibit significant difference between the two groups. This suggests that the levels of these growth factors may be unaffected by the periodontal disease.


Subject(s)
Chronic Periodontitis , Insulin-Like Growth Factor I , Intercellular Signaling Peptides and Proteins , Platelet-Rich Fibrin , Transforming Growth Factor beta1 , Vascular Endothelial Growth Factor A , Humans , Chronic Periodontitis/blood , Pilot Projects , Male , Female , Adult , Middle Aged , Vascular Endothelial Growth Factor A/blood , Insulin-Like Growth Factor I/analysis , Intercellular Signaling Peptides and Proteins/blood , Intercellular Signaling Peptides and Proteins/analysis , Transforming Growth Factor beta1/blood , Epidermal Growth Factor/blood , Epidermal Growth Factor/analysis , Leukocyte Count , Becaplermin/blood , Case-Control Studies , Blood Platelets/metabolism , Injections
2.
J Laryngol Otol ; 138(5): 520-526, 2024 May.
Article in English | MEDLINE | ID: mdl-38380493

ABSTRACT

OBJECTIVE: To investigate epidermal growth factor, transforming growth factor-α and interleukin-8 production in nasal mucosa irrigated with hypertonic 2.3 per cent solution with algae extracts, in comparison to 0.9 per cent NaCl during the first two weeks after surgery for nasal polyposis, in relation to symptoms and local findings. METHODS: This prospective study included 20 nasal polyposis patients postoperatively irrigated with hypertonic solution and 20 nasal polyposis patients postoperatively irrigated with isotonic solution. We evaluated nasal symptom score, endoscopic score and mediator levels in nasal secretions before and after irrigation. RESULTS: Following treatment, nasal symptom score and endoscopic score were significantly lower in the hypertonic solution group (p = 0.023; p < 0.001, respectively). The increase in the epidermal growth factor and the decrease in the transforming growth factor-α and interleukin-8 concentration were higher in the hypertonic group (p < 0.001 for all mediators). CONCLUSION: Irrigation with a hypertonic solution was found to be more effective than an isotonic solution in nasal mucosa reparation.


Subject(s)
Epidermal Growth Factor , Interleukin-8 , Nasal Lavage , Nasal Mucosa , Nasal Polyps , Seawater , Transforming Growth Factor alpha , Humans , Nasal Polyps/surgery , Nasal Polyps/metabolism , Male , Female , Prospective Studies , Interleukin-8/metabolism , Interleukin-8/analysis , Adult , Middle Aged , Nasal Mucosa/metabolism , Nasal Mucosa/drug effects , Nasal Lavage/methods , Epidermal Growth Factor/analysis , Epidermal Growth Factor/metabolism , Transforming Growth Factor alpha/metabolism , Transforming Growth Factor alpha/analysis , Endoscopy/methods , Hypertonic Solutions , Aged , Young Adult
3.
OMICS ; 26(8): 440-450, 2022 08.
Article in English | MEDLINE | ID: mdl-35900271

ABSTRACT

Breastfeeding reduces the risk of necrotizing enterocolitis (NEC), one of the most common causes of morbidity and mortality in preterm infants. However, the molecular substrates by which human milk (HM) offers protection against NEC are not well known. Using fetal intestinal epithelial cells treated with known NEC aggravators, namely lipopolysaccharide (LPS) and platelet-activating factor (PAF), we mapped the time-course of changes in targeted expression analysis of 35 NEC-associated genes, so-called the NEC signature. We found, first, that HM treatment fully rescued LPS/PAF-induced fetal intestinal cell death at 12 and 24 h (n = 5). Differential gene expression and bioinformatics revealed that HM did not mitigate inflammatory and cell death signals, but instead promoted cell proliferation and stress response pathways to mitigate LPS/PAF-induced inflammatory cell death. From this, epidermal growth factor (EGF) synthesis emerged as the central player in rescue of the fetal intestinal cell death. Functional validation was supported by reversal of the cellular rescue by HM following EGF knockdown by small interfering RNA. In conclusion, this study suggests that HM might offer protection against NEC through enhancing intestinal EGF production to rescue the inflammatory cell death. Future studies are warranted to verify these HM molecular protective effects in NEC models in vivo. The findings reported herein also support future research avenues to discover new therapeutics to boost intrinsic EGF production in the injured intestinal tissues in neonates with NEC, for example, by bioactive components in human milk, natural compounds, or small molecules.


Subject(s)
Enterocolitis, Necrotizing , Enterocolitis, Necrotizing/genetics , Enterocolitis, Necrotizing/metabolism , Epidermal Growth Factor/analysis , Epidermal Growth Factor/pharmacology , Epithelial Cells , Humans , Infant , Infant, Newborn , Infant, Premature , Lipopolysaccharides/adverse effects , Lipopolysaccharides/analysis , Milk, Human/chemistry
4.
Esophagus ; 19(2): 351-359, 2022 04.
Article in English | MEDLINE | ID: mdl-34536162

ABSTRACT

BACKGROUND: Salivary secretion in patients with mild reflux esophagitis has not been examined. In this study, saliva secretion and salivary epidermal growth factor (EGF) in patients with mild reflux esophagitis were investigated. METHODS: Thirty-eight mild reflux esophagitis patients and 38 control subjects were recruited for this case-control study. Saliva secretion testing was performed. Saliva secretion was assessed as follows: each patient chewed sugar-free gum for 3 min prior to endoscopy, and the volume and pH of saliva before and after acid loading as an index of the acid-buffering capacity were measured. The salivary EGF concentration was assessed by ELISA. RESULTS: The volume of saliva secreted was significantly (p = 0.0412) lower in the mild reflux esophagitis group than in the control group, with medians (25th-75th percentile) of 4.2 mL/3 min [2.6-6.2] and 6.0 [3.9-8.0], respectively. No significant differences were observed in salivary pH (the mild reflux esophagitis group: 7.1 [6.9-7.2], the control group 7.2 [7.1-7.3]). Salivary pH after acid loading was significantly (p = 0.0009) lower in the mild reflux esophagitis group (5.9 [5.5-6.3]) than in the control group (6.3 [6.2-6.5]). No significant differences were noted in salivary EGF concentrations (the mild reflux esophagitis group: 1739.0 pg/mL [1142.3-3329.0], the control group: 1678.0 [1091.8-2122.5]. CONCLUSION: The secretion volume and acid-buffering capacity of stimulated saliva were reduced in patients with mild reflux esophagitis.


Subject(s)
Esophagitis, Peptic , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Epidermal Growth Factor/analysis , Epidermal Growth Factor/metabolism , Humans , Saliva/metabolism
5.
PLoS One ; 16(4): e0249209, 2021.
Article in English | MEDLINE | ID: mdl-33891598

ABSTRACT

Activated platelet-rich plasma (PRP) has been used in the clinical settings of wound healing and regenerative medicine, with activation typically induced by the addition of bovine thrombin. To eliminate issues with availability, cost and potential side effects associated with bovine thrombin, ex vivo PRP activation using pulse electric fields (PEF) has been proposed and demonstrated. The present study characterizes the effect of PEF voltage and pulse width, in combination with a range of calcium concentrations, on clot formation, growth factor release, and serotonin (5-HT) release from dense granules. The main findings are: 1) increasing calcium concentrations with most PEF conditions leads to increased levels of PDGF and 5-HT release; 2) whether EGF levels increase or decrease with increasing calcium concentration depends on the specific PEF parameters; 3) the pattern of PDGF and EGF levels in supernatants suggest that these molecules are localized differently within platelets; 4) significant levels of PDGF, EGF, and 5-HT can be released without inducing clot formation or hemoglobin release. In conclusion, voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobin from PEF-activated PRP. Because growth factor requirements vary for different types of wounds and for wounds at different stages of healing, the unique balance of factors in supernatants of PEF-activated PRP may provide more clinically advantageous than the current standard of bovine thrombin-activated PRP.


Subject(s)
Electricity , Epidermal Growth Factor/analysis , Hemoglobins/analysis , Platelet-Derived Growth Factor/analysis , Platelet-Rich Plasma/metabolism , Serotonin/analysis , Blood Cell Count , Calcium/chemistry , Calcium/pharmacology , Enzyme-Linked Immunosorbent Assay , Epidermal Growth Factor/metabolism , Hemoglobins/metabolism , Humans , Platelet Activation/drug effects , Platelet-Derived Growth Factor/metabolism , Serotonin/metabolism
6.
Crit Care ; 25(1): 39, 2021 01 28.
Article in English | MEDLINE | ID: mdl-33509215

ABSTRACT

BACKGROUND: The EMiC2 membrane is a medium cut-off haemofilter (45 kiloDalton). Little is known regarding its efficacy in eliminating medium-sized cytokines in sepsis. This study aimed to explore the effects of continuous veno-venous haemodialysis (CVVHD) using the EMiC2 filter on cytokine clearance. METHODS: This was a prospective observational study conducted in critically ill patients with sepsis and acute kidney injury requiring kidney replacement therapy. We measured concentrations of 12 cytokines [Interleukin (IL) IL-1ß, IL-1α, IL-2, IL-4, IL-6, IL-8, IL-10, interferon (IFN)-γ, tumour necrosis factor (TNF)-α, vascular endothelial growth factor, monocyte chemoattractant protein (MCP)-1, epidermal growth factor (EGF)] in plasma at baseline (T0) and pre- and post-dialyzer at 1, 6, 24, and 48 h after CVVHD initiation and in the effluent fluid at corresponding time points. Outcomes were the effluent and adsorptive clearance rates, mass balances, and changes in serial serum concentrations. RESULTS: Twelve patients were included in the final analysis. All cytokines except EGF concentrations declined over 48 h (p < 0.001). The effluent clearance rates were variable and ranged from negligible values for IL-2, IFN-γ, IL-1α, IL-1ß, and EGF, to 19.0 ml/min for TNF-α. Negative or minimal adsorption was observed. The effluent and adsorptive clearance rates remained steady over time. The percentage of cytokine removal was low for most cytokines throughout the 48-h period. CONCLUSION: EMiC2-CVVHD achieved modest removal of most cytokines and demonstrated small to no adsorptive capacity despite a decline in plasma cytokine concentrations. This suggests that changes in plasma cytokine concentrations may not be solely influenced by extracorporeal removal. TRIAL REGISTRATION: NCT03231748, registered on 27th July 2017.


Subject(s)
Acute Kidney Injury/etiology , Cytokines/metabolism , Metabolic Clearance Rate/physiology , Sepsis/complications , Acute Kidney Injury/physiopathology , Aged , Chemokine CCL2/analysis , Chemokine CCL2/blood , Epidermal Growth Factor/analysis , Epidermal Growth Factor/blood , Female , Humans , Interferon-gamma/analysis , Interferon-gamma/blood , Interleukin-10/analysis , Interleukin-10/blood , Interleukin-1alpha/analysis , Interleukin-1alpha/blood , Interleukin-1beta/analysis , Interleukin-1beta/blood , Interleukin-2/analysis , Interleukin-2/blood , Interleukin-4/analysis , Interleukin-4/blood , Interleukin-6/analysis , Interleukin-6/blood , Male , Middle Aged , Peptide Fragments/analysis , Peptide Fragments/blood , Prospective Studies , Renal Replacement Therapy/methods , Sepsis/physiopathology , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/blood , Vascular Endothelial Growth Factors/analysis , Vascular Endothelial Growth Factors/blood
7.
Mol Biotechnol ; 63(1): 13-23, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33051823

ABSTRACT

Seeds have evolutionarily developed to store protein without immediately degrading it and constitute ideal tissues for recombinant protein storage. Unfortunately, the production of recombinant protein in seeds is compromised by low yield as compared to other heterologous expression systems. In order to improve the yield of the human epidermal growth factor (EGF) in barley, protein sink-source relations in the developing grain were modulated towards EGF instead of the barley storage protein. The EGF gene, under the control of a B-hordein and a seed-specific oat globulin promoter, was introduced by crossing EGF lines into the Risø 56 mutant deficient in B-hordein storage protein synthesis. Offspring plants were analysed for EGF and Hordein expression and for expression of the unfolded protein response (UPR) genes PDI and CRT to monitor changes in ER stress levels. EGF content was increased significantly in the mature grain of homozygous offspring and PDI and CRT gene expressions were upregulated. We demonstrate, for the first time in barley, that replacement of an abundant seed storage protein with a specific heterologous protein driven by the promoter of the removed gene can accelerate the production of a specific heterologous protein in barley grains.


Subject(s)
Epidermal Growth Factor/metabolism , Glutens/metabolism , Grain Proteins/metabolism , Hordeum/metabolism , Molecular Farming/methods , Plant Proteins/metabolism , Unfolded Protein Response/genetics , Epidermal Growth Factor/analysis , Epidermal Growth Factor/genetics , Gene Expression , Glutens/analysis , Glutens/genetics , Grain Proteins/analysis , Homozygote , Hordeum/genetics , Humans , Plant Proteins/genetics , Plants, Genetically Modified , Promoter Regions, Genetic , Recombinant Proteins , Seeds/genetics , Seeds/metabolism
8.
Biosensors (Basel) ; 10(8)2020 Aug 05.
Article in English | MEDLINE | ID: mdl-32764513

ABSTRACT

The frequency shift of a shear-horizontal surface-acoustic-wave (SH-SAW) biosensor in which the concentration of biomolecule is determined by the amount of its adsorption on the sensing film was studied. Simulation results were compared with experimental results to investigate its sensitivity and to develop a model to estimate the concentration of a cancer-related biomarker antigen epidermal growth factor (EGF) in the sample, with two types of sensing films, 3-aminopropyltriethoxysilane (APTES) and glutaraldehyde. With the concentration of the targeted biomarker varying from 0.2 to 5 ng/mL, a typical exponential relationship was found between the concentration and the frequency shift of the SH-SAW sensor. Measurement results showed a clear response of this immunosensor to the mass-loading effects of the antibody-antigen. The sensitivity of the glutaraldehyde film is greater than that of the APTES film owing to the chemisorption of the antibody. In the simulation, a shift of the SH-SAW resonant frequency due to added mass occurred on applying an incremental surface mass density on the sensing film, while in real applications, the concentration of the targeted biomarker to be absorbed in the sensing film is demanded. An empirical model was proposed to calculate the frequency shift in the simulation of the SH-SAW biosensor, corresponding to the concentration of specific biomolecules absorbed on a specific film. From the semi-empirical model, the sensitivity level is found to be 0.641 and 1.709 kHz/(ng/mL) for APTES and glutaraldehyde sensing films, respectively, at a biomarker concentration of less than 1 ng/mL. The developed method is useful for quickly estimating the frequency shift with respect to the concentration of the target molecules in the simulation for SH-SAW sensors.


Subject(s)
Epidermal Growth Factor/analysis , Glutaral/chemistry , Propylamines/chemistry , Silanes/chemistry , Acoustics , Biosensing Techniques/methods , Equipment Design , Sound , Surface Properties
9.
Biomolecules ; 10(5)2020 04 28.
Article in English | MEDLINE | ID: mdl-32354031

ABSTRACT

Age-related macular degeneration (AMD) is one of the leading causes of visual loss in western countries, it has no cure, and its incidence will grow in the future, for the overall population aging. Albino rats with retinal degeneration induced by exposure to high-intensity light (light-damage, LD) have been extensively used as a model of AMD to test neuroprotective agents. Among them, trophic factors (NGF and BDNF) have been shown to play a significant role in photoreceptors' survival. Interestingly, cord blood serum (CBS) is an extract full of chemokines and trophic factors; we, therefore, hypothesized that CBS could be an excellent candidate for neuroprotection. Here, we investigate whether CBS-based eye drops might mitigate the effects of light-induced retinal degeneration in albino rats. CBS treatment significantly preserved flash-electroretinogram (f-ERG) response after LD and reduced the "hot-spot" extension. Besides, CBS-treated animals better preserved the morphology of the outer nuclear layer, together with a reduction in microglia migration and activation. Interestingly, the treatment did not modulate reactive gliosis and activation of the self-protective mechanism (FGF2). In conclusion, our results suggest that CBS-based eye drops might be successfully used to mitigate retinal neurodegenerative processes such as AMD.


Subject(s)
Fetal Blood/chemistry , Macular Degeneration/drug therapy , Neuroprotective Agents/pharmacology , Ophthalmic Solutions/pharmacology , Photoreceptor Cells/drug effects , Animals , Epidermal Growth Factor/analysis , Epidermal Growth Factor/pharmacology , Female , Humans , Interleukins/analysis , Interleukins/pharmacology , Light/adverse effects , Macular Degeneration/etiology , Microglia/drug effects , Nerve Growth Factors/analysis , Nerve Growth Factors/pharmacology , Neuroprotective Agents/chemistry , Neuroprotective Agents/therapeutic use , Ophthalmic Solutions/chemistry , Ophthalmic Solutions/therapeutic use , Rats , Rats, Sprague-Dawley , Serum/chemistry
10.
Am J Surg Pathol ; 44(8): 1092-1103, 2020 08.
Article in English | MEDLINE | ID: mdl-32317606

ABSTRACT

To date, the apocrine variant of lobular carcinoma in situ (AP-LCIS) has been cursorily described as a subtype of lobular carcinoma in situ (LCIS). We retrospectively reviewed 34 cases of AP-LCIS (including 23 associated with invasive lobular carcinoma) to fully characterize it. AP-LCIS typically presented with screen-detected calcifications in older women (mean age: 65 y) and was characterized by distended terminal duct lobular units with relatively large "pleomorphic" cells, central necrosis, and calcifications. AP-LCIS cells exhibited abundant eosinophilic occasionally granular cytoplasm, hyperchromatic nuclei, and prominent nucleoli. Synchronous classic and/or florid LCIS was identified in 24/34 (70%) AP-LCIS, and in 9/11 (82%) pure AP-LCIS. Most (68%) cases of AP-LCIS were estrogen receptor-positive (50% strongly), 35% were progesterone receptor-positive, 26% were human epidermal growth factor 2-positive, 18% demonstrated high-proliferation rate (Ki67: >15%), and 90% were androgen receptor-positive. Aurora kinase A, immunoreactive in 38% of AP-LCIS cases, was not significantly associated with recurrence, development of invasion, or nodal positivity (P>0.05). Compared with conventional (nonapocrine) pleomorphic lobular carcinoma in situ (P-LCIS), aurora kinase A was expressed in a significantly greater proportion of P-LCIS (100%). AP-LCIS and P-LCIS did not otherwise differ in clinicopathologic features. Next-generation sequencing utilizing the Oncomine Comprehensive Panel v2, performed on 27 AP-LCIS cases, showed no specific molecular findings. In a mean follow-up of 57 months, 2 (of 11, 18%) pure AP-LCIS cases recurred (2 both in situ and invasive) and none metastasized or proved fatal. AP-LCIS should be regarded as another high-grade LCIS similar to P-LCIS in many respects, and pending additional studies should be managed similarly.


Subject(s)
Apocrine Glands , Breast Carcinoma In Situ/classification , Breast Neoplasms/classification , Aged , Apocrine Glands/chemistry , Apocrine Glands/pathology , Aurora Kinase A/analysis , Breast Carcinoma In Situ/chemistry , Breast Carcinoma In Situ/genetics , Breast Carcinoma In Situ/pathology , Breast Neoplasms/chemistry , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Calcinosis , Cell Proliferation , Databases, Factual , Epidermal Growth Factor/analysis , Female , Humans , Ki-67 Antigen/analysis , Middle Aged , Necrosis , Neoplasm Recurrence, Local , Prognosis , Receptors, Androgen/analysis , Receptors, Progesterone/analysis , Retrospective Studies
11.
Mol Syst Biol ; 16(2): e8870, 2020 02.
Article in English | MEDLINE | ID: mdl-32090487

ABSTRACT

How cells utilize surface receptors for chemoreception is a recurrent question spanning between physics and biology over the past few decades. However, the dynamical mechanism for processing time-varying signals is still unclear. Using dynamical systems formalism to describe criticality in non-equilibrium systems, we propose generic principle for temporal information processing through phase space trajectories using dynamic transient memory. In contrast to short-term memory, dynamic memory generated via "ghost" attractor enables signal integration depending on stimulus history and thereby uniquely promotes integrating and interpreting complex temporal growth factor signals. We argue that this is a generic feature of receptor networks, the first layer of the cell that senses the changing environment. Using the experimentally established epidermal growth factor sensing system, we propose how recycling could provide self-organized maintenance of the critical receptor concentration at the plasma membrane through a simple, fluctuation-sensing mechanism. Processing of non-stationary signals, a feature previously attributed only to neural networks, thus uniquely emerges for receptor networks organized at criticality.


Subject(s)
Epidermal Growth Factor/analysis , ErbB Receptors/metabolism , Systems Biology/methods , Animals , Cell Membrane/metabolism , Humans , Neural Networks, Computer , Spatio-Temporal Analysis
12.
Am J Ophthalmol ; 213: 260-266, 2020 05.
Article in English | MEDLINE | ID: mdl-32006480

ABSTRACT

PURPOSE: To analyze the biological stability of autologous serum eyedrops after lyophilization. DESIGN: Prospective, comparative experimental study. METHODS: This was a comparative study with serum obtained from 12 healthy volunteers. The concentrations of different epitheliotropic factors (eg, transforming growth factor-ß [TGF-ß1], epidermal growth factor [EGF], platelet-derived growth factor AB [PDGF-AB], and albumin) were measured in fresh and lyophilized serum. The samples were studied after serum preparation (fresh serum) and immediately after saline solution reconstitution of lyophilized serum (0), 15, and 30 days later. The biological effects of both serum samples were also compared on conjunctival and corneal cell cultures. The pH, osmolarity, and serum density were also determined. RESULTS: No significant differences were found in the concentration of growth factors between fresh serum and re-dissolved serum samples after lyophilization. The concentration of growth factors remained stable during 1 month at 4°C in re-dissolved lyophilized form with saline solution. No differences were found related to osmolarity, pH, and density between fresh and lyophilized serum. In addition, no differences were found on the conjunctival and corneal cells proliferation and differentiation in cells cultures between either serum preparation. CONCLUSIONS: The properties of autologous serum remain after lyophilization. The lyophilized serum can be easily stored without temperature restrictions and easily reconstituted for preparation of eyedrops for standard clinical use.


Subject(s)
Epidermal Growth Factor/analysis , Ophthalmic Solutions/chemistry , Platelet-Derived Growth Factor/analysis , Serum Albumin, Human/analysis , Serum/chemistry , Transforming Growth Factor beta1/analysis , Adult , Cell Differentiation/physiology , Cell Movement/physiology , Cell Proliferation/physiology , Cells, Cultured , Drug Stability , Drug Storage , Epithelium, Corneal/drug effects , Freeze Drying , Healthy Volunteers , Humans , Hydrogen-Ion Concentration , Microscopy, Phase-Contrast , Middle Aged , Osmolar Concentration , Prospective Studies
13.
Cell Tissue Bank ; 20(4): 579-583, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31612289

ABSTRACT

Amniotic membrane has been widely applied as a biological graft in both medical and veterinary practice. In ophthalmology, epidermal growth factor (EGF) in human amniotic membrane (HAM) promotes corneal epithelial cell proliferation and migration, thus it facilitates corneal wound healing. In dogs, with limited cryopreserved HAM availability, different cold glycerol preserving protocols have been developed for the storage canine amniotic membrane (CAM). This study aimed to study protein expression of EGF in CAM preserved with different concentrations of glycerol and storage temperatures, using enzyme-linked immunosorbent assay. CAM preserved in 50% glycerol and 99.5% glycerol and kept at 4 and - 20 °C for 7-30 days were compared. We found that preserving membrane with 50% glycerol at - 20 °C has significantly higher EGF protein expression compared with that at 4 °C (p < 0.05). There was a trend that the storage in 50% glycerol achieved higher EGF protein expression than 99.5% glycerol at both 4 °C and - 20 °C. In conclusion, 50% glycerol at - 20 °C was the best condition to preserve CAM in our study. Therefore, there is likely an alternative method to maintain level of EGF protein expression in preserved CAM.


Subject(s)
Amnion/metabolism , Cryopreservation/methods , Cryoprotective Agents/metabolism , Epidermal Growth Factor/analysis , Glycerol/metabolism , Animals , Dogs , Epidermal Growth Factor/metabolism , Female , Temperature , Tissue Preservation/methods
14.
Psychoneuroendocrinology ; 109: 104415, 2019 11.
Article in English | MEDLINE | ID: mdl-31472432

ABSTRACT

Growth factors, such as vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), and neurotrophic factors, including brain-derived neurotophic factor (BDNF), have attracted attention in studies of the biological effects of long-term stress exposure due to their neuroprotective roles. This study investigated whether circulating levels of EGF, VEGF and BDNF were altered in individuals with stress-related exhaustion disorder. Forty patients diagnosed with exhaustion disorder and 40 healthy subjects (50% women) provided fasting blood samples for analysis of EGF, VEGF, and BDNF in plasma. We found significantly lower levels of EGF, VEGF, and BDNF in patients with ED compared to healthy controls. This pattern was seen in both male and female patients. Given the important roles of BDNF and VEGF for brain plasticity and neurogenesis, decreased levels after long-term stress exposure could indicate increased risk of neuronal damage and cognitive impairments in this patient group.


Subject(s)
Burnout, Professional/metabolism , Neuronal Plasticity/physiology , Stress, Psychological/metabolism , Adult , Brain/metabolism , Brain-Derived Neurotrophic Factor/analysis , Brain-Derived Neurotrophic Factor/blood , Brain-Derived Neurotrophic Factor/metabolism , Burnout, Professional/psychology , Epidermal Growth Factor/analysis , Epidermal Growth Factor/blood , Epidermal Growth Factor/metabolism , Female , Humans , Male , Neurogenesis/physiology , Psychophysiologic Disorders/metabolism , Psychophysiologic Disorders/psychology , Vascular Endothelial Growth Factor A/analysis , Vascular Endothelial Growth Factor A/blood , Vascular Endothelial Growth Factor A/metabolism
15.
Clin Chem Lab Med ; 57(12): 1948-1955, 2019 Nov 26.
Article in English | MEDLINE | ID: mdl-31323001

ABSTRACT

Background The epidermal growth factor receptor (EGFR) system is involved in cancer pathogenesis and serves as an important target for multiple cancer treatments. EGFR and its ligands epidermal growth factor (EGF), heparin-binding epidermal growth factor (HB-EGF), betacellulin (BTC), amphiregulin (AREG) and transforming growth factor α (TGF-α) have potential applications as prognostic or predictive serological biomarkers in cancer. The aim was to establish EGFR and EGFR ligand reference intervals in healthy women. Methods EGFR and EGFR ligands were measured in serum from 419 healthy women aged 26-78 years. The need for age partitioned reference intervals was evaluated using Lahti's method. EGFR and EGF were analyzed using ELISA assays, whereas HB-EGF, BTC, AREG and TGF-α were analyzed using the highly sensitive automated single molecule array (Simoa) enabling detection below the lower reference limit for all six biomarkers. Results Reference intervals for EGFR and the EGFR ligands were determined as the 2.5th and 97.5th percentiles. All six biomarkers were detectable in all serum samples. For EGFR, EGF, HB-EGF and TGF-α, reference intervals were established for women <55 years and for women >55 years, whilst common reference intervals were established for AREG and BTC including women aged 26-78 years. Conclusions Age specific reference intervals were determined for EGFR, EGF, HB-EGF, BTC, AREG and TGF-α.


Subject(s)
EGF Family of Proteins/analysis , Adult , Aged , Amphiregulin/analysis , Amphiregulin/blood , Betacellulin/analysis , Betacellulin/blood , Biomarkers/blood , EGF Family of Proteins/blood , Epidermal Growth Factor/analysis , Epidermal Growth Factor/blood , ErbB Receptors/analysis , ErbB Receptors/blood , Female , Heparin-binding EGF-like Growth Factor/analysis , Heparin-binding EGF-like Growth Factor/blood , Humans , Ligands , Middle Aged , Reference Standards , Reference Values , Transforming Growth Factor alpha/analysis , Transforming Growth Factor alpha/blood
16.
Cell Tissue Bank ; 20(2): 163-172, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31062125

ABSTRACT

The purpose of the current study was to compare the effects of drying and fresh-freezing on human amniotic membrane (HAM) and amnion/chorion membrane (HACM) in terms of histological and structural characteristics and cytokine levels. HAM and HACM samples, obtained from six placentae, were investigated. HAM and HACM were dried, electron beam-irradiated (dehydration group; d-HAM/d-HACM), or fresh-frozen (freezing group; f-HAM/f-HACM). Luminex assay was used to assay the levels of 15 cytokines. The ultrastructural characteristics of HAM and HACM were evaluated using light and transmission electron microscopies. Total cytokine contents did not show the statistical difference between dehydration and fresh-freezing process. Significantly higher levels of total cytokines were observed in HACM than in HAM. Epidermal growth factor (EGF) level was significantly higher in d-HAM than in the other samples. The levels of most of the other growth factors were higher in HACM than in HAM, but there was no statistical difference between the dehydration process and the fresh-freezing process. The levels of the cytokines, other than the growth factors, were higher in HACM than in HAM, and higher concentrations of cytokines were observed in the freezing group than in the dehydration group. Histological examination revealed that the dehydration group had thinner tissues than the freezing group, but the structural stability, including the basement membrane, did not differ between the two groups. Microscopic structures such as microvilli and nuclei were well-preserved in the freezing group, based on the results of the transmission electron microscopy. Our dehydration process maintained the histological structure of HAM/HACM and a variety of growth factors and cytokines were identified. Especially, the HAM, processed with the dehydration method, had a higher EGF level than that processed with the fresh-freezing method. Therefore, dehydration method can be used to effectively promote wound repair.


Subject(s)
Amnion/metabolism , Chorioallantoic Membrane/metabolism , Chorion/metabolism , Cryopreservation/methods , Cytokines/analysis , Placenta/metabolism , Amnion/radiation effects , Chorioallantoic Membrane/radiation effects , Chorion/radiation effects , Desiccation , Electrons , Epidermal Growth Factor/analysis , Female , Freeze Drying , Humans , Microscopy, Electron, Transmission , Placenta/radiation effects , Pregnancy
17.
Int J Biol Macromol ; 133: 624-639, 2019 Jul 15.
Article in English | MEDLINE | ID: mdl-31004648

ABSTRACT

Growth factors are necessary for proper and efficient wound closure and tissue regeneration. Epidermal growth factor (EGF) is one of the key signaling molecules in stimulating epithelial cell motility, making it a required factor for re-epithelialization. Increased EGF expression is likely to be a strong prognostic and predictive feature in multiple tumor types and determination of EGF may product remarkable diagnosis benefits. Thus, identification and quantification of EGF in biomedical fields are particularly important. Affinity chromatography, immunohistochemical methods and ELISA, conventional methods for EGF detection, requiring high-cost and complicated instrumentation, take too much time and offer deficient sensitivity and selectivity, which restrict their usage in real applications. Hence, it is essential to design and build enhanced systems and platforms for the recognition and quantification of protein biomarkers. In the past few years, bio-assays have been received noticeable attention for the detection of EGF owing to their high sensitivity, selectivity, accuracy, fast response, and low cost. Since the role and importance of developing aptasensors in cancer diagnosis is undeniable. In this review, electrochemical biosensors, which have been applied by many researchers for EGF cancer biomarker detection, have been mentioned and merits and demerits of them have been explained and compared. Efforts related to design and development of aptamer-based biosensors using nanoparticles for sensitive and selective detection of EGF have been reviewed considering: Aptamer importance as recognition elements, principal, application and the recent improvements and developments of aptamer based optical and electrochemical methods. In addition, commercial biosensors and future perspectives for rapid and on-site detection of EGF have been summarized.


Subject(s)
Biosensing Techniques/methods , Epidermal Growth Factor/analysis , Animals , DNA/metabolism , Electrochemistry , Humans , Immunoassay
19.
Theranostics ; 9(4): 1085-1095, 2019.
Article in English | MEDLINE | ID: mdl-30867817

ABSTRACT

Epidermal growth factor receptor (EGFR) is overexpressed in many types of cancers, which is associated with metastatic potential and poor prognosis in cancer patients. Therefore, development of EGFR-targeted sensitive imaging probes has been a challenge in tumor targeting, image-guided cancer surgery, patient-selective anti-EGFR therapy, and efficient targeted therapies. Methods: We synthesized a zwitterionic near-infrared fluorophore (ATTO655)-conjugated epidermal growth factor (EGF) as a novel activatable molecular probe. Fluorescence OFF/ON property and EGFR-targeting specificity of EGF-ATTO655 as well as its utility in real-time near-infrared (NIR) fluorescence imaging of EGFR-positive cancers were evaluated using in vitro and in vivo studies. Results: When conjugated to EGF, the fluorescence of ATTO655 quenched efficiently by photo-induced electron transfer (PET) mechanism between the conjugated dyes and nearby amino acid quenchers (tryptophan/tyrosine residues), which was stably maintained at physiological pH and in the presence of serum for at least 17 h. The fluorescence of EGF-ATTO655 turned on by receptor-mediated endocytosis and subsequent disintegration of EGF in EGFR-positive A431 cancer cells, thereby enabling specific and real-time fluorescence imaging of EGFR-positive cancer cells. Consequently, EGFR-positive tumors could be clearly visualized 3 h post-injection with a significantly high tumor-to-background ratio (TBR = 6.37). Conclusion: This PET mechanism-based OFF/ON type of EGF probe showed great potential for rapid, real-time, and target-cell-specific imaging of EGFR-overexpressing cancers in vitro and in vivo.


Subject(s)
Epidermal Growth Factor/analysis , ErbB Receptors/metabolism , Fluorescent Dyes/analysis , Neoplasms/diagnostic imaging , Optical Imaging/methods , Staining and Labeling/methods , Animals , Cell Line, Tumor , Disease Models, Animal , Humans , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Transplantation, Heterologous
20.
Int Breastfeed J ; 14: 9, 2019.
Article in English | MEDLINE | ID: mdl-30792750

ABSTRACT

Background: Breast milk provides nutrition for infants and also contains a variety of bioactive factors that influence the development of the newborn. Human milk is a complex biological fluid that can be separated into different layers (water phase and lipid phase with its component water and lipid fractions). It can affect the developing human body along the whole length of the gastrointestinal tract, and through the circulation, its factors may reach every organ. Methods: In the present study, we analyzed milk samples collected monthly for 6 months from 16 mothers from the 4th week postpartum between 2014 and 2016 in Baranya County, Hungary. The 96 samples provided us information about the fluctuation of certain bioactive factors during the first 6 months of lactation. We investigated with Luminex technology the concentrations of several cytokines (CD40, Flt-3L), chemokines (MCP-1, RANTES, GRO, MIP-1ß, MDC, eotaxin, fractalkine), and epidermal growth factor (EGF). Paired t-tests and one-way ANOVA followed by Bonferroni post-hoc tests were used to compare the data. Results: We detected the presence of each bioactive factor in every layer of the milk samples during the first 6 months of breastfeeding in widespread concentration ranges. In the case of GRO, MIP-1ß, MDC, Flt-3L, fractalkine, and eotaxin, the concentrations were constant during the first 6 months of lactation. The water phase of human milk contained higher factor concentrations compared to both fractions of the lipid phase for most factors (except eotaxin and MIP-1ß). The concentrations of CD40, EGF, MCP-1, and RANTES in the first 3 months were significantly different compared to the values detected between 4th and 6th months. In the water phase, the level of MCP-1 was significantly decreased, while all of the other factors increased during the 4th through 6th months. We found significantly higher EGF, GRO, and RANTES levels in the water fraction compared to the lipid fraction of the lipid phase. Conclusions: The novel findings of this investigation were the presence of Flt-3L and MDC in all layers of breast milk, and nearly all bioactive factors in the lipid phase. Due to their widespread physiological effects these factors may have an essential role in organogenesis.


Subject(s)
Milk, Human/chemistry , Adult , Chemokines/analysis , Cytokines/analysis , Epidermal Growth Factor/analysis , Female , Humans , Lactation
SELECTION OF CITATIONS
SEARCH DETAIL
...